XML 29 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Pay vs Performance Disclosure
Unit_pure in Millions
 1 Months Ended 9 Months Ended 12 Months Ended
Jan. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Pay vs Performance Disclosure [Table]          
Pay vs Performance [Table Text Block]    
Pay Versus Performance Disclosure
As required by the Dodd-Frank Act and Item 402(v) of Regulation S-K, the Pay versus
Performance
disclosure that follows provides information about the relationship between Compensation Actually Paid, or CAP, to our Principal Executive Officer, or PEO, and Non-PEO NEOs and certain financial performance measures of the company. See the Compensation Discussion and Analysis within this proxy statement for further information concerning the company’s variable pay-for-performance philosophy and how the company aligns executive compensation with company performance.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value of initial fixed $100
Investment based on:
 
 
 
 
 
 
 
Year
 
Summary
Compensation
Table
Total for PEO
(Blanchard)
 
 
Summary
Compensation
Table Total
for Other
PEO
(Darling)
 
 
Compensation
Actually Paid
to PEO
(Blanchard)
 
 
Compensation
Actually Paid
to Other PEO
(Darling)
 
 
Average
Summary
Compensation
Table Total for
non-PEO NEOs
 
 
Average
Compensation
Actually Paid to
non-PEO
NEOs
 
 
Total
Shareholder
Return
 
 
Peer Total
Shareholder
Return
 
 
Net
Income
($mm)
 
 
Revenue
($mm)
 
 
 
(a)
 
 
 
(b)
 
 
 
(a)
 
 
 
(b)
 
 
 
(c)
 
 
 
(c)
 
 
 
(d)
 
 
 
(d)
 
 
 
(e)
 
 
 
(e)
 
2022
   $ 5,940,722       N/A     $ 3,599,763       N/A     $ 1,739,011     $ 1,406,419     $ 57     $ 111     ($ 15 )    $ 156  
2021
   $ 4,202,608       N/A     $ 1,818,313       N/A     $ 1,234,846     $ 1,051,797     $ 69     $ 125     $ 4     $ 148  
2020
   $ 10,029,434     $ 288,753     $ 10,513,388     ($ 7,088,313 )    $ 1,411,154     $ 772,039     $ 87     $ 126     ($ 24 )    $ 130  
 
(a)
Dr. Blanchard
served as interim CEO for part of 2020 and was appointed President and CEO in April 2020.
(b)
Mr. Darling
, CEO at the beginning of 2020, passed away unexpectedly in January 2020. All of Mr. Darling’s unvested equity was forfeited upon his death.
(c)
NEOs in 2022 include Messrs. Levitz and Colleran, NEOs in 2021 include Messrs. Levitz, Colleran, Thomas Finnerty and James Loerop. Mr. Loerop, the company’s EVP, Business Development and Strategic Planning, resigned in January 2022. Mr. Finnerty, the company’s EVP, Human Resources, retired in March 2022. NEOs in 2020 include Messrs. Levitz, Colleran, Finnerty, Loerop and Sylvia Cheung. Ms. Cheung, the company’s CFO, resigned in August 2020. Mr. Colleran joined the company as EVP, General Counsel and Secretary in March 2020, and Mr. Levitz joined company as EVP, CFO and Treasurer in August 2020.
(d)
Shareholder return is based on $100 investment at the beginning of 2020. Peer shareholder return is based on the NASDAQ Biotechnology Index.
(e)
Net Income and
Revenue
are as reported in the company’s Annual Report on Form 10-K for each fiscal year referenced.
 
    
Company Selected Measure Name     Revenue    
Named Executive Officers, Footnote [Text Block]    
(c)
NEOs in 2022 include Messrs. Levitz and Colleran, NEOs in 2021 include Messrs. Levitz, Colleran, Thomas Finnerty and James Loerop. Mr. Loerop, the company’s EVP, Business Development and Strategic Planning, resigned in January 2022. Mr. Finnerty, the company’s EVP, Human Resources, retired in March 2022. NEOs in 2020 include Messrs. Levitz, Colleran, Finnerty, Loerop and Sylvia Cheung. Ms. Cheung, the company’s CFO, resigned in August 2020. Mr. Colleran joined the company as EVP, General Counsel and Secretary in March 2020, and Mr. Levitz joined company as EVP, CFO and Treasurer in August 2020.
   
Peer Group Issuers, Footnote [Text Block]     Shareholder return is based on $100 investment at the beginning of 2020. Peer shareholder return is based on the NASDAQ Biotechnology Index.    
Adjustment To PEO Compensation, Footnote [Text Block]    
The following table sets forth a reconciliation from the summary compensation table (SCT) to compensation actually paid (CAP) to our PEO and to our average
non-PEO
NEO each year.
 
 
 
PEO (Blanchard)
 
 
PEO (Darling)
 
 
Average NEO
 
 
 
2022
 
 
2021
 
 
2020
 
 
2020
 
 
2022
 
 
2021
 
 
2020
 
SCT Total Compensation
  
$
5,940,722
 
  
$
4,202,608
 
  
$
10,029,434
 
  
$
288,753
 
   
$
1,739,011
 
  
$
1,234,846
 
  
$
1,411,154
 
SUBTRACT Grant Fair Value of Equity Awards Made During
Year (a)
   ($ 4,630,341 )    ($ 2,942,637 )    ($ 8,994,889 )    $ 0      ($ 1,051,440 )    ($ 658,333 )    ($ 962,952 ) 
ADD Year End Fair Value of Equity Awards Made During Year
(b)
   $ 5,294,178     $ 3,254,974     $ 9,337,528     $ 0      $ 1,205,238     $ 728,209     $ 668,806  
ADD Year over Year Change in Fair Value of Outstanding and
Unvested Equity Awards (c)
   ($ 1,016,462 )    ($ 2,470,476 )    $ 0     $ 0      ($ 274,828 )    ($ 189,171 )    ($ 64,142 ) 
ADD Year over Year Change in Fair Value of Equity Awards
Granted in Prior Year that Vested in the Year (d)
   ($ 1,988,334 )    ($ 226,155 )    $ 0      ($ 18,351 )    ($ 211,562 )    ($ 63,754 )    ($ 83,186 ) 
 
 
 
 
PEO (Blanchard)
 
 
PEO (Darling)
 
 
Average NEO
 
 
 
2022
 
 
2021
 
 
2020
 
 
2020
 
 
2022
 
 
2021
 
 
2020
 
ADD Fair Value at Vesting of Equity Awards Made During Year
That Also Vested During Year (e)
   $ 0     $ 0     $ 141,315     $ 0     $ 0     $ 0     $ 0  
SUBTRACT Fair Value at the End of the Prior Year of Equity
Awards that Were Forfeited During Year (f)
   $ 0     $ 0     $ 0     ($ 7,358,716 )    $ 0     $ 0     ($ 197,641 ) 
Total Adjustments Related to Equity Awards
  
($
2,340,959
) 
  
($
2,384,295
) 
  
$
483,954
 
  
($
7,377,066
) 
  
($
332,592
) 
  
($
183,048
) 
  
($
639,115
) 
Compensation Actually Paid Total
  
$
3,599,763
 
  
$
1,818,313
 
  
$
10,513,388
 
  
($
7,088,313
) 
  
$
1,406,419
 
  
$
1,051,797
 
  
$
772,039
 
 
(a)
Represents the grant date fair value of equity-based awards made during the fiscal year.
(b)
Represents the
year-end
fair value of equity awards that were made during the fiscal year.
(c)
Represents the change in fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of
year-end.
(d)
Represents the change in fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.
(e)
Represents the fair value on the vesting date of equity-based awards that vested in the same year as granted. In 2020, Dr. Blanchard received a grant of RSUs for her service as interim Chief Executive Officer between February and April 2020, which RSUs fully vested upon her permanent appointment as President and CEO in April 2020.
(f)
Represents the prior year-end fair value of equity awards that were forfeited by other PEOs who terminated during the year. Mr. Darling passed away unexpectedly in early 2020, and unvested equity awards were forfeited upon his death.. Ms. Cheung resigned in August 2020 and all unvested equity awards were forfeited upon her resignation.
    
Non-PEO NEO Average Total Compensation Amount     $ 1,739,011 $ 1,234,846 $ 1,411,154
Non-PEO NEO Average Compensation Actually Paid Amount     $ 1,406,419 1,051,797 772,039
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]    
The following table sets forth a reconciliation from the summary compensation table (SCT) to compensation actually paid (CAP) to our PEO and to our average
non-PEO
NEO each year.
 
 
 
PEO (Blanchard)
 
 
PEO (Darling)
 
 
Average NEO
 
 
 
2022
 
 
2021
 
 
2020
 
 
2020
 
 
2022
 
 
2021
 
 
2020
 
SCT Total Compensation
  
$
5,940,722
 
  
$
4,202,608
 
  
$
10,029,434
 
  
$
288,753
 
   
$
1,739,011
 
  
$
1,234,846
 
  
$
1,411,154
 
SUBTRACT Grant Fair Value of Equity Awards Made During
Year (a)
   ($ 4,630,341 )    ($ 2,942,637 )    ($ 8,994,889 )    $ 0      ($ 1,051,440 )    ($ 658,333 )    ($ 962,952 ) 
ADD Year End Fair Value of Equity Awards Made During Year
(b)
   $ 5,294,178     $ 3,254,974     $ 9,337,528     $ 0      $ 1,205,238     $ 728,209     $ 668,806  
ADD Year over Year Change in Fair Value of Outstanding and
Unvested Equity Awards (c)
   ($ 1,016,462 )    ($ 2,470,476 )    $ 0     $ 0      ($ 274,828 )    ($ 189,171 )    ($ 64,142 ) 
ADD Year over Year Change in Fair Value of Equity Awards
Granted in Prior Year that Vested in the Year (d)
   ($ 1,988,334 )    ($ 226,155 )    $ 0      ($ 18,351 )    ($ 211,562 )    ($ 63,754 )    ($ 83,186 ) 
 
 
 
 
PEO (Blanchard)
 
 
PEO (Darling)
 
 
Average NEO
 
 
 
2022
 
 
2021
 
 
2020
 
 
2020
 
 
2022
 
 
2021
 
 
2020
 
ADD Fair Value at Vesting of Equity Awards Made During Year
That Also Vested During Year (e)
   $ 0     $ 0     $ 141,315     $ 0     $ 0     $ 0     $ 0  
SUBTRACT Fair Value at the End of the Prior Year of Equity
Awards that Were Forfeited During Year (f)
   $ 0     $ 0     $ 0     ($ 7,358,716 )    $ 0     $ 0     ($ 197,641 ) 
Total Adjustments Related to Equity Awards
  
($
2,340,959
) 
  
($
2,384,295
) 
  
$
483,954
 
  
($
7,377,066
) 
  
($
332,592
) 
  
($
183,048
) 
  
($
639,115
) 
Compensation Actually Paid Total
  
$
3,599,763
 
  
$
1,818,313
 
  
$
10,513,388
 
  
($
7,088,313
) 
  
$
1,406,419
 
  
$
1,051,797
 
  
$
772,039
 
 
(a)
Represents the grant date fair value of equity-based awards made during the fiscal year.
(b)
Represents the
year-end
fair value of equity awards that were made during the fiscal year.
(c)
Represents the change in fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of
year-end.
(d)
Represents the change in fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.
(e)
Represents the fair value on the vesting date of equity-based awards that vested in the same year as granted. In 2020, Dr. Blanchard received a grant of RSUs for her service as interim Chief Executive Officer between February and April 2020, which RSUs fully vested upon her permanent appointment as President and CEO in April 2020.
(f)
Represents the prior year-end fair value of equity awards that were forfeited by other PEOs who terminated during the year. Mr. Darling passed away unexpectedly in early 2020, and unvested equity awards were forfeited upon his death.. Ms. Cheung resigned in August 2020 and all unvested equity awards were forfeited upon her resignation.
    
Compensation Actually Paid vs. Total Shareholder Return [Text Block]        
Compensation Actually Paid vs. Net Income [Text Block]        
Compensation Actually Paid vs. Company Selected Measure [Text Block]        
Total Shareholder Return Vs Peer Group [Text Block]        
Tabular List [Table Text Block]     The following table sets forth what we consider to be the most important financial performance measures in how CAP was linked to company performance during 2022.
Key Financial Measures
Revenues
Gross Margin
Adjusted EBITDA
    
Total Shareholder Return Amount     $ 57 69 87
Peer Group Total Shareholder Return Amount     111 125 126
Net Income (Loss)     $ (15,000,000) $ 4,000,000 $ (24,000,000)
Company Selected Measure Amount     156 148 130
PEO Name     Dr. Blanchard Dr. Blanchard  
Measure [Axis]: 1          
Pay vs Performance Disclosure [Table]          
Measure Name     Revenues    
Non-GAAP Measure Description [Text Block]    
Net Income and
Revenue
are as reported in the company’s Annual Report on Form 10-K for each fiscal year referenced.
    
Measure [Axis]: 2          
Pay vs Performance Disclosure [Table]          
Measure Name     Gross Margin    
Measure [Axis]: 3          
Pay vs Performance Disclosure [Table]          
Measure Name     Adjusted EBITDA    
Dr. Blanchard [Member]          
Pay vs Performance Disclosure [Table]          
PEO Total Compensation Amount   $ 10,029,434 $ 5,940,722 $ 4,202,608 $ 10,029,434
PEO Actually Paid Compensation Amount   $ 10,513,388 3,599,763 1,818,313 10,513,388
PEO Name   Dr. Blanchard      
Mr. Darling [Member]          
Pay vs Performance Disclosure [Table]          
PEO Total Compensation Amount $ 288,753       288,753
PEO Actually Paid Compensation Amount $ (7,088,313)       (7,088,313)
PEO Name Mr. Darling        
PEO [Member] | Dr. Blanchard [Member] | Grant Fair Value of Equity Awards Made During Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     (4,630,341) (2,942,637) (8,994,889)
PEO [Member] | Dr. Blanchard [Member] | Year End Fair Value of Equity Awards Made During Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     5,294,178 3,254,974 9,337,528
PEO [Member] | Dr. Blanchard [Member] | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     (1,016,462) (2,470,476) 0
PEO [Member] | Dr. Blanchard [Member] | Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in the Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     (1,988,334) (226,155) 0
PEO [Member] | Dr. Blanchard [Member] | Fair Value at Vesting of Equity Awards Made During Year That Also Vested During Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     0 0 141,315
PEO [Member] | Dr. Blanchard [Member] | Fair Value at the End of the Prior Year of Equity Awards that Were Forfeited During Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     0 0 0
PEO [Member] | Dr. Blanchard [Member] | Adjustments Related to Equity Awards [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     (2,340,959) (2,384,295) 483,954
PEO [Member] | Mr. Darling [Member] | Grant Fair Value of Equity Awards Made During Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount         0
PEO [Member] | Mr. Darling [Member] | Year End Fair Value of Equity Awards Made During Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount         0
PEO [Member] | Mr. Darling [Member] | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount         0
PEO [Member] | Mr. Darling [Member] | Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in the Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount         (18,351)
PEO [Member] | Mr. Darling [Member] | Fair Value at Vesting of Equity Awards Made During Year That Also Vested During Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount         0
PEO [Member] | Mr. Darling [Member] | Fair Value at the End of the Prior Year of Equity Awards that Were Forfeited During Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount         (7,358,716)
PEO [Member] | Mr. Darling [Member] | Adjustments Related to Equity Awards [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount         (7,377,066)
Non-PEO NEO [Member] | Grant Fair Value of Equity Awards Made During Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     (1,051,440) (658,333) (962,952)
Non-PEO NEO [Member] | Year End Fair Value of Equity Awards Made During Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     1,205,238 728,209 668,806
Non-PEO NEO [Member] | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     (274,828) (189,171) (64,142)
Non-PEO NEO [Member] | Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in the Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     (211,562) (63,754) (83,186)
Non-PEO NEO [Member] | Fair Value at Vesting of Equity Awards Made During Year That Also Vested During Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     0 0 0
Non-PEO NEO [Member] | Fair Value at the End of the Prior Year of Equity Awards that Were Forfeited During Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     0 0 (197,641)
Non-PEO NEO [Member] | Adjustments Related to Equity Awards [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount     $ (332,592) $ (183,048) $ (639,115)